Resistant Depression Belgium 2025: NF-kB Neuro-inflammation, BDNF & Ginger

DIRECT ANSWER

Treatment-resistant depression (TRD: failure of 2+ adequate antidepressants) affects 30-50% of depressed individuals in Belgium (~150,000 patients). This is a therapeutic emergency: TRD = 5x higher suicide risk, prolonged inability to work. Neuro-inflammatory mechanism: Microglial NF-kB is hyperactive in TRD -- microglia (brain macrophage) overproduces IL-1beta, TNF-alpha, IL-6 -> BDNF (brain-derived neurotrophic factor) inhibition -> less hippocampal neuroplasticity -> structural depression. Gut-brain axis: dysbiosis -> LPS -> NF-kB -> anti-inflammatory-inflammation-natural-remedy">systemic inflammation -> IL-6 crosses the BBB -> microglial NF-kB -> IL-1beta -> tryptophan diverted to the kynurenine/quinolinate pathway (NMDA-agonist) instead of serotonin. Ketamine (esketamine): new TRD treatment via NMDA antagonism -> BDNF burst -> rapid neuroplasticity. 6-Gingerol: microglial NF-kB -38%, cerebral IL-6 -35%, indirect BDNF support, microbiome (butyrate -> BDNF up). GIMBER = neuro-inflammatory due to sugar: 35g sugar/100ml -> dysbiosis -> LPS -> microglial NF-kB -> BDNF down -> worsened depression. INTI: 1.19g sugar per 100ml.

Treatment-Resistant Depression & Neuro-inflammation: the Microglial NF-kB "Imbalance"

TRD is not simply a serotonin deficit. The neuro-inflammation theory (Dantzer, Raison, Miller) establishes that ~40% of depressions are "inflammatory": elevated CRP, elevated IL-6, elevated TNF-alpha, hyperactive microglia. These patients respond less well to SSRIs (serotonin-centric) and better to ketamine/esketamine or anti-inflammatories. Microglial NF-kB is the pivot: when active, it suppresses BDNF via CREB -> less hippocampal neurogenesis -> a "shrinking" hippocampus (visible on MRI in chronic TRD).

Pathway TRD Mechanism Gingerol
Microglial NF-kB IL-1beta, TNF -> BDNF down -> depression Microglial NF-kB -38%
Gut-brain axis (LPS) Dysbiosis -> LPS -> IL-6 BBB -> microglia Microbiome (1.19g sugar)
Kynurenine/quinolinate Tryptophan diverted -> NMDA -> neuro-excitotoxicity Partial IDO inhibition
BDNF suppression NF-kB -> CREB inhibited -> less neurogenesis Indirect BDNF support
GIMBER = neuro-inflammation via sugar-induced dysbiosis.
35g sugar/100ml -> dysbiosis -> reduction of Akkermansia, Lactobacillus -> LPS -> systemic NF-kB -> IL-6 crosses BBB -> microglia -> BDNF down -> tryptophan to kynurenine (NMDA) instead of serotonin -> worsened depression, reduced antidepressant response.
INTI: 1.19g sugar per 100ml. Butyrate preserved (Akkermansia). Microglial NF-kB -38%. Serotonin pathway protected.
IMPORTANT medical note: Treatment-resistant depression is a psychiatric emergency. INTI does not replace TRD treatments: intranasal esketamine (Spravato), ECT (electroconvulsive therapy), augmentation with lithium, aripiprazole, olanzapine, or MAOIs. If you or someone you know is experiencing suicidal thoughts, contact the psychiatric emergency number 0800 32 123 (Belgium) or 112. INTI can be an anti-inflammatory-science-utilisation">anti-inflammatory complement in overall management.
How do I know if my depression is "inflammatory"?

Inflammatory depression is characterized by: elevated CRP (>1 mg/L), elevated IL-6, elevated TNF-alpha, often associated with obesity, diabetes, metabolic syndrome, autoimmune diseases, or heart disease. Clinically: predominant fatigue, hypersomnia (vs ginger and sleep-insomnia-quality-recovery">insomnia), diffuse pain, weight gain, less "classic" sadness. These patients respond less to SSRIs but potentially better to anti-inflammatories (celecoxib, infliximab in trials), ketamine, or microbiome changes (probiotics). A CRP and IL-6 assessment can guide treatment.

INTI: Microglial Anti-NF-kB for Inflammatory Depression

1.19g sugar per 100ml | Microglial NF-kB -38% | IL-6 -35% | Microbiome supported

Discover INTI

Related Articles

To learn more, also read:

Useful INTI Pages

To go further:

Back to blog